Regulatory News
Wednesday, July 13, 2016
Allergan extends Teva deal closing date by three months
July 13 (Reuters) - Allergan Plc said the closing of
a deal to sell its generic business to Teva Pharmaceutical
Industries Ltd would be extended by three months to
October.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment